应对新冠肺炎期间武汉市接受抗病毒治疗艾滋病患者缺药风险评估  被引量:5

Antiretrovial Treatment Discontinuation Risk Assessment of HIV/AIDS Patients in Wuhan During the response of COVID-19

在线阅读下载全文

作  者:胡雪姣 谢年华[1] 闫晗 阮连国 罗燕和 刘恋 张倩[4] 王兵 高明[6] 王夏[1] HU Xuejiao;XIE Nianhua;YAN Han;RUAN Lianguo;LUO Yanhe;LIU Lian;ZHANG Qian;WANG Bing;GAO Ming;WANG Xia(Department for HIV/AIDS Prevention and Control,Wuhan Center for Disease Control and Prevention,Wuhan 430024,China;Jinyintan Hospital,Wuhan 430040;Caidian District Center for Disease Control and Prevention,Wuhan 430100;Qingshan District Center for Disease Control and Prevention,Wuhan 430080;Huangpi District Center for Disease Control and Prevention,Wuhan 430300;.Xinzhou District Center for Disease Control and Prevention,Wuhan 430400)

机构地区:[1]武汉市疾病预防控制中心艾滋病防制所,武汉430024 [2]武汉市金银潭医院,武汉430040 [3]武汉市蔡甸区疾病预防控制中心,武汉430100 [4]武汉市青山区疾病预防控制中心,武汉430080 [5]武汉市黄陂区疾病预防控制中心,武汉430300 [6]武汉市新洲区疾病预防控制中心,武汉430400

出  处:《中国艾滋病性病》2021年第5期519-522,共4页Chinese Journal of Aids & STD

基  金:武汉市卫生和计划生育委员会医学科研项目面上重点项目(WG17A02)。

摘  要:目的探索特殊情况下艾滋病患者抗病毒治疗药物保障措施。方法应对新型冠状病毒肺炎(简称新冠肺炎)期间采用电话调查的方法了解2020年1月1日至3月8日武汉市艾滋病患者抗病毒治疗药物领取情况,根据调查结果评估并解决其缺药风险。结果截至3月8日,武汉市正在接受抗病毒治疗艾滋病患者5517人,经评估5095人(92.35%)未来15天无缺药风险,228人(4.13%)缺药低风险,194人(3.52%)已缺药。疫情应对期间共4500人领药,其中2084人(46.31%)门诊自行取药,157人(3.49%)通过疾病预防控制中心或防艾志愿者上门送药获得药物,1735人(38.56%)通过邮寄方式获得药物,524人(11.64%)外地门诊借药。结论应对新冠肺炎期间,武汉市在治艾滋病患者存在缺药风险,但通过设立应急制度并提供多种取药途径,有效降低了缺药风险人群比例。Objective To explore antiretroviral medicine safeguards for HIV/AIDS patients in extreme conditions.Methods We used a telephone survey to investigate the antiretroviral treatment situation of HIV/AIDS patients in Wuhan from January 1 st to March 8th,2020,assessed and solved the risk of ART discontinuation for these HIV/AIDS patients.Results A total of 5517 HIV/AIDS patients were receiving antiviral treatment in Wuhan until March 8th.We found that 92.35%of them with no risk of ART discontinuation,4.13%facing the risk of discontinuation in the next 15 days and 3.52%had discontinued.During the response of COVID-19,4500 people received antiretroviral medicines.2084(46.31%)of them went to the clinic for their medicines,157(3.49%)were delivered by local CDC or social volunteers,1735(38.56%)received the medicines by express delivery and 524(11.64%)borrowed medicine from other cities.Conclusion Although the supply of antiretroviral drugs against HIV have been disrupted during the pandemic of COVID-19 in Wuhan,the proportion of patients with ART discontinued has been effectively reduced by setting up an emergency system and providing a variety manners of drug access.

关 键 词:新型冠状病毒肺炎 艾滋病 抗病毒治疗 风险评估 

分 类 号:R512.91[医药卫生—内科学] R373.9[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象